"Designing Growth Strategies is in our DNA"

Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Size, Share and Global Trend By Drug Class (Alpha-1 proteinase inhibitor, Bronchodilators, Steroids, Antibiotics), By Route of Administration (Oral, Injection, Inhalation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores), and Geography Forecast till 2026

The global alpha-1 antitrypsin deficiency treatment market size expected to drive significant growth by 2026. Alpha-1 antitrypsin is one of the protein synthesised in the... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Upcoming | Report ID: FBI100189 | Status : Upcoming

 

Request PDF Brochure

Refresh Button
Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2017
  • Choose License Type
  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X